Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: NEDA-3 After Re-Baselining in the Phase 3 EVOLVE-MS-1 Study
富马酸二甲酯治疗复发缓解型多发性硬化症患者:EVOLVE-MS-1 3 期研究中重新基线后的 NEDA-3 数据
期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-02901-1
Bowen, James D; Stulc, Jessica; Hunter, Samuel F; Chen, Hailu; Lewin, James B; Scaramozza, Matthew; Bozin, Ivan; Then Bergh, Florian